Epidemiology and prevention of hepatitis B

Seminars in Liver Disease

Volumn 23, Issue 1, 2003, Pages 39-46

  Alter, Miriam J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Epidemiology; Hepatitis B; Prevention

Indexed keywords

HEPATITIS B VACCINE;

BLOOD DONOR; CHRONIC LIVER DISEASE; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 0037330951     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37583     Document Type: Review

References (99)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13(Suppl 1):S47-S49
2. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956
3. Alter HJ, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen - positive saliva and semen. Infect Immun 1977;16:928-933
4. Bancroft WH, Snitbhan R, Scott RM, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis 1977;135:79-85
5. Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 1976;295:909-913
6. Hindman SH, Gravelle CR, Murphy BL, et al. "e" antigen, Dane particles and serum DNA polymerase activity in HBsAg carriers. Ann Intern Med 1976;85:458-460
7. Shikata T, Karasawa T, Abe K, et al. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977;136:571-576
8. The Incident Investigation Team and Others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178-184
9. Alter HJ, Purcell RH, Holland PV, et al. Clinical and serological analysis of transfusion-associated hepatitis. Lancet 1975; 2:838-841
10. Seeff LB, Wright EC, Zimmerman HJ, et al. VA cooperative study of post-transfusion hepatitis and responsible risk factors. Am J Med Sci 1975;270:355-362
11. Hutin YJ, Harpaz R, Drobeniuc J, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999;28:782-786
12. Alter MJ, Ahtone J, Maynard JE. Multiple-dose vial associated with transmission of hepatitis B virus in a hemodialysis unit. Ann Intern Med 1983;99:330-333
13. Polish LB, Shapiro CN, Bauer F, et al. Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device. N Engl J Med 1992;326:721-725
14. Hutin YJ, Goldstein ST, Varma JK, et al. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999;20:731-735
15. Drescher J, Wagner D, Haverich A, et al. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 1994;26:81-92
16. Lettau L, McCarthy JG, Smith MH, et al. An outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987;317:1256-1261
17. Mast EE, Alter MJ. Prevention of hepatitis B virus infection among health care workers. In: Ellis RS, ed. Hepatitis B Vaccines in Clinical Practice. New York: Marcel Dekker; 1992: 295-307
18. Limentani AE, Elliott LM. An outbreak of hepatitis B from tattooing. Lancet 1979;2:86-88
19. Kent GB, Brondum J, Keenlyside RA, LaFazia LM, Scott HD. A large outbreak of acupuncture-associated hepatitis B. Am J Epidemiol 1988;127:591-598
20. Bond WW, Favero MS, Petersen NJ, et al. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1:550-551
21. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001; 50(RR-5):1-43
22. Quale JM, Landman D, Wallace B, et al. Déjà vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med 1998;105:296-301
23. Douvin C, Simon D, Zinelabidine H, et al. An outbreak of hepatitis B in an endocrinology unit traced to a capillaryblood-sampling device. N Engl J Med 1990;322:57-58
24. Vickers J, Painter MJ, Heptonstall J, Yusaf JHM, Craske J. Hepatitis B outbreak in a drug trials unit: investigation and recommendations. Commun Dis Rep 1994;4:R1-R5
25. Oren I, Hershow RC, Ben-Porath E, et al. A common-source outbreak of fulminant hepatitis B in a hospital. Ann Intern Med 1989;110:691-698
26. Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization. Am J Epidemiol 1982;115:26-39
27. Hadler SC, Doto IL, Maynard JE, et al. Occupational risk of hepatitis B infection in hospital workers. Infect Control 1985; 6:24-31
28. Mahoney FJ, Stewart K, Hu H, et al. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997; 157:2601-2605
29. Carl M, Blakey DL, Francis DP, Maynard JE. Interruption of hepatitis B transmission by modification of a gynaecologist's surgical technique. Lancet 1982;1:731-733
30. Lettau LA, Smith JD, Williams D, et al. Transmission of hepatitis B with resultant restriction of surgical practice. JAMA 1986;255:934-937
31. Prendergast TJ, Teitelbaum S, Peck B. Transmission of hepatitis B by a surgeon [letter]. West J Med 1991;154:353
32. Levin ML, Maddrey WC, Wands JR, Mendeloff AI. Hepatitis B transmission by dentists. JAMA 1974;228:1139-1140
33. Goodwin D, Fannin ST, McCracken BB. An oral-surgeon related hepatitis-B outbreak. Calif Morbid 1976;14:1-2
34. Rimland D, Parkin WE, Miller GB, Schrack WD. Hepatitis B outbreak traced to an oral surgeon. N Engl J Med 1977; 296:953-958
35. Hadler SC, Sorley DL, Acree KH, et al. An outbreak of hepatitis B in a dental practice. Ann Intern Med 1981;95:133-138
36. Reingold AL, Kane MA, Murphy BL, et al. Transmission of hepatitis B by an oral surgeon. J Infect Dis 1982;145:262-268
37. Ahtone J, Goodman RA. Hepatitis B and dental personnel: transmission to patients and prevention issues. J Am Dent Assoc 1983;106:219-222
38. Goodman RA, Ahtone JL, Finton RJ. Hepatitis B transmission from dental personnel to patients: unfinished business [editorial]. Ann Intern Med 1983;96:119
39. Shaw FE, Barrett CL, Hamm R, et al. Lethal outbreak of hepatitis B in a dental practice. JAMA 1986;255:3260-3264
40. CDC. Outbreak of hepatitis B associated with an oral surgeon - New Hampshire. MMWR Morb Mortal Wkly Rep 1987;38:132-133
41. Public Health Laboratory Service. Acute hepatitis B associated with gynaecological surgery: A report of a collaborative study by the Communicable Disease Surveillance Centre and the Epidemiological Research Laboratory of the Public Health Laboratory Service together with a district controlof-infection service. Lancet 1980;1:595-596
42. Haerem JW, Siebke JC, Ulstrup J, Geiran O, Helle I. HBsAg transmission from a cardiac surgeon incubating hepatitis B resulting in chronic antigenemia in four patients. Acta Med Scand 1981;210:389-392
43. District Control of Infection Officer. Acute hepatitis B following gynaecological surgery. J Hosp Infect 1987;9:34-38
44. Coutinho RA, Albrecht-van Lent P, Stoutjesdijk L, et al. Hepatitis B from doctors [letter]. Lancet 1982;1:345-346
45. Polakoff S. Acute hepatitis B in Britain related to previous operations and dental treatment. Br Med J 1986;293:33-36
46. Welch J, Webster M, Tilzey AJ, Noah ND. Hepatitis B infections after gynaecological surgery. Lancet 1989;1:205-207
47. Polakoff S. Acute viral hepatitis B, reported to the Public Health Laboratory Service. J Infect 1990;20:163-168
48. Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff. Commun Dis Rep 1991;1: R81-R85
49. Prentice MB, Flower AJE, Morgan GM, et al. Infection with hepatitis B virus after open heart surgery. Br Med J 1992;304: 761-764
50. Johnston BL, MacDonald S, Lee S, et al. Nosocomial hepatitis B associated with orthopedic surgery - Nova Scotia. Can Commun Dis Rep 1992;18:89-90
51. Snydman DR, Hindman SH, Wineland MD, Bryan JA, Maynard JE. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients. Ann Intern Med 1976;85:573-577
52. Grob PJ, Bischof B, Naeff F. Cluster of hepatitis B transmitted by a physician. Lancet 1981;2:1218-1220
53. Johnson I. Hepatitis B - EEG clinics outbreak investigation: final report, January 1997. Ontario Ministry of Health, Toronto, Canada
54. Harpaz R, Von Seidlin L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549-554
55. Spijkerman IJB, van Doorn L-J, Janssen MHW, et al. Transmission of hepatitis B virus from a surgeon to his patients during high-risk low-risk surgical procedures during 4 years. Infect Control Hosp Epidemiol 2002;23:306-312
56. Stevens CE, Neurath RA, Beasley RP, et al. HBeAg and antiHBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979;3:237-241
57. Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 1990;74:1529-1541
58. Centers for Disease Control. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigenpositive saliva. Morbidity and Mortality Weekly Report 1978;27:247-248
59. Glaser JB, Nadler JP. Hepatitis B virus in a cardiopulmonary resuscitation training course. Arch Intern Med 1985;145:1653-1655
60. Xu ZY, Liu CB, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized double-blind placebo-controlled and comparative trial. Pediatrics 1985;76:713-718
61. Beasley RP, Hwang L-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147:185-190
62. Franks AL, Berg CJ, Kane MA, et al. Hepatitis B infection among children born in the United States to Southeast Asian refugees. N Engl J Med 1989;321:1301-1305
63. Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992;89:269-273
64. Toukan AU, Sharaiha ZK, Abu-el-rub OA, et al. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol 1990;132:220-232
65. Pon EW, Ren HX, Margolis HS, et al. Hepatitis B virus infection in Honolulu students. Pediatrics 1993;92:574-578
66. Bernier RH, Sampliner R, Gerety R, et al. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol 1982;116:199-211
67. Szmuness W, Harley EJ, Prince AM. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 1975;270:293-304
68. Petersen NJ, Barrett DH, Bond WH, et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 1976;32:572-574
69. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92
70. Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans, 4th ed. New York: Plenum Medical Book; 1997:363-418
71. Bogomolski-Yahalom V, Granot E, Linder N, et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. J Med Virol 1991;34:217-222
72. Germinario C, Lopalco PL, Chicanna M, Da Villa G. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine 2000;18:S83-S85
73. Spada E, Mele A, Ciccozzi M, et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis 2001;33:778-784
74. Van Steenbergen JE, Niesters HGM, Op de Coul ELM, et al. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol 2002;66:159-165
75. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002;185:713-719
76. Connolly JH, McClelland WM, O'Neill HJ, Crowley D. Hepatitis B virus infection in Northern Ireland 1970-1987. Ulster Med J 1989;58:72-82
77. Brabin B, Beeching NJ, Bunn JEG, et al. Hepatitis B prevalence among Somali households in Liverpool. Arch Dis Child 2002;86:67-68
78. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report 1991;40(RR-13):1-25
79. Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission in the United States. Morbidity and Mortality Weekly Report 1995;44:574-575
80. Healy CM, Cafferkey MT, Butler KM, et al. Antenatal hepatitis B screening - is there a need for a national policy? Irish Med J 2001;94:111-112
81. Van Steenbergen JE, Leentvaar-Kuijpers A, Baayen D, et al. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998. Vaccine 2001;20:7-11
82. Salleras L, Bruguera M, Vidal J, et al. Prevalence of markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992;8:640-644
83. Da Villa G. Rationale for the infant and adolescent vaccination programmes in Italy. Vaccine 2000;18:S31-S34
84. Magdzik W. Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 2000;18:S13-S16
85. Popa IM, Pistol A, Mast EE, et al. Use of surveillance for acute hepatitis among children to assess the impact of routine infant hepatitis B vaccination programs in Romania. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. Atlanta: International Medical Press; 2002:261-262
86. Ni Y-H, Chang M-H, Huang L-M, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800
87. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859
88. Da Villa G, Sepe A, Piccinino F, Scolastico C. Pilot project of universal hepatitis B vaccination of newborns in a hyperendemic area: results after 17 years. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. Atlanta: International Medical Press; 2002:258-260
89. Armstrong GL, Mast EE, Wojczynski M, Margolis HS. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. Pediatrics 2001;108:1123-1128
90. Centers for Disease Control. Current trends in hepatitis B virus vaccine safety: report of an inter-agency group. MMWR 1982;31:465-467
91. Centers for Disease Control. Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR 1984;33: 685-687
92. Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines - a review. Vaccine 1998;16:329-324
93. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001; 344:319-326
94. Ascherio A, Zhang SM, Hernán MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-332
95. Institute of Medicine Immunization Safety Review Committee. In: Stratton K, Almario D, McCormick MC, eds. Hepatitis B Vaccine and Demyelinating Disorders, 2002. Washington, DC: National Academy Press; 2002:1-106
96. Francois G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 2001;19:3799-3815
97. Hsu H-Y, Chang M-H, Liaw S-H, Ni Y-H, Chen H-L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;30:1312-1317
98. Nainan OV, Khristova ML, Byun K-S, et al. Frequency and significance of hepatitis B virus antibody resistant mutants. Antiviral Ther 2000;5(Suppl):29-30(Abst)
99. Ogata N, Cote PJ, Zanetti AR, et al. Licensed recombinant hepatitis B vaccine protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 1999;30:779-786